Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

Despite early confusion over efficacy and the initial paucity of data in older age groups, 1 the
Oxford-AstraZeneca vaccine (ChAdOx1) has been shown to be highly effective, especially at …

Background Although several studies have assessed the risk of venous thromboembolism
with newer hormonal contraception, few have examined thrombotic stroke and myocardial …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

Objective To assess the risk of venous thrombosis in current users of different types of
hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and …

Objective To assess the thrombotic risk associated with oral contraceptive use with a focus
on dose of oestrogen and type of progestogen of oral contraceptives available in the …

Background Acne is a common skin disorder among women. Although no uniform approach
to the management of acne exists, combination oral contraceptives (COCs), which contain …

Objective To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial
infarction associated with combined oral contraceptives according to dose of oestrogen …